Assembly Biosciences, Inc.
(NASDAQ : ASMB)

( )
ASMB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
0.24%178.580.4%$137.09m
PRGOPerrigo Co. Plc
0.48%73.346.8%$93.10m
JAZZJazz Pharmaceuticals Plc
0.68%163.032.2%$71.22m
MNKMallinckrodt Plc
-0.40%29.6721.1%$65.61m
ENDPEndo International Plc
0.13%15.968.9%$57.71m
GWPHGW Pharmaceuticals PLC Sponsored ADR
2.98%153.646.8%$51.91m
PTLAPortola Pharmaceuticals, Inc.
1.31%28.637.7%$39.01m
UTHRUnited Therapeutics Corporation
-0.27%125.8614.4%$38.69m
SAGESAGE Therapeutics, Inc.
-1.45%144.839.6%$36.37m
CTLTCatalent Inc
-0.33%42.742.4%$36.15m
ICPTIntercept Pharmaceuticals, Inc.
-1.03%119.3618.7%$32.09m
SUPNSupernus Pharmaceuticals, Inc.
2.13%47.906.2%$28.67m
PCRXPacira Pharmaceuticals, Inc.
7.32%51.3510.6%$27.64m
ZGNXZogenix, Inc.
-3.29%47.0510.0%$27.47m
MDCOMedicines Company
-0.18%33.6021.8%$24.49m

Company Profile

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin on October 7, 2005 and is headquartered in Carmel, IN.